Progestins are used in hormone replacement therapies to counteract the negative effects of oestrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used...
- Breast cancer risk varies among different progestins used in hormone replacement therapyTue, 10 Aug 2010, 16:16:25 EDT
- Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapyMon, 13 Jul 2009, 12:43:20 EDT
- Breast cancer drug shows promise for treating, preventing progestin-dependent tumorsWed, 28 Jan 2009, 14:37:05 EST
- Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study findsThu, 6 May 2010, 12:50:59 EDT
- Breast tenderness during hormone replacement therapy linked to elevated cancer riskMon, 12 Oct 2009, 16:34:43 EDT